Immune-mediated complications during interferon therapy in hematological patients.
作者： Pia Raanani , Isaac Ben-Bassat
DOI: 10.1159/000057631
关键词:
摘要: Interferon (IFN), a leukocyte-derived cytokine, has been used to treat several hematological malignancies. The most common adverse effects of IFN are flu-like symptoms. Autoimmune side inf
karger.com
sci-hub.se 参考文章(79)
Bobbio-Pallavicini E, Porta C, Tacconi F, Valsecchi C, Moroni M, Sarcoidosis following beta-interferon therapy for multiple myeloma. Sarcoidosis. ,vol. 12, pp. 140- 142 ,(1995)
Saito E, Shimizu Y, Segawa F, Kinoshita M, Behçet's disease induced by interferon therapy for chronic myelogenous leukemia. The Journal of Rheumatology. ,vol. 22, pp. 1183- 1184 ,(1995)
Fefer A, Kempf R, Cooper Mr, Thompson J, Bickers J, Scarffe Jh, Spiegel R, Neefe J, Sacher R, Case Dc, Alpha-2-interferon/melphalan/prednisone in previously untreated patients with multiple myeloma: a phase I-II trial. Cancer treatment reports. ,vol. 70, pp. 473- 476 ,(1986)
T Takeda, T Inoue, M Okamura, Y Kanayama, N Negoro, T Kim, Serum levels of interferons in patients with systemic lupus erythematosus. Clinical and Experimental Immunology. ,vol. 70, pp. 562- 569 ,(1987)
John Laszlo, David Goldstein, Interferon therapy in cancer: from imaginon to interferon. Cancer Research. ,vol. 46, pp. 4315- 4329 ,(1986)
S Sacchi, H Kantarjian, S O'Brien, P R Cohen, S Pierce, M Talpaz, Immune-mediated and unusual complications during interferon alfa therapy in chronic myelogenous leukemia. Journal of Clinical Oncology. ,vol. 13, pp. 2401- 2407 ,(1995) , 10.1200/JCO.1995.13.9.2401
J R Quesada, M Talpaz, A Rios, R Kurzrock, J U Gutterman, Clinical toxicity of interferons in cancer patients: a review. Journal of Clinical Oncology. ,vol. 4, pp. 234- 243 ,(1986) , 10.1200/JCO.1986.4.2.234
Andreas Creutzig, The Raynaud Phenomenon and Interferon Therapy Annals of Internal Medicine. ,vol. 125, pp. 423- 423 ,(1996) , 10.7326/0003-4819-125-5-199609010-00025
P. McLaughlin, Immune thrombocytopenia following alpha-interferon therapy in patients with cancer. JAMA. ,vol. 254, pp. 1353- 1354 ,(1985) , 10.1001/JAMA.254.10.1353
Michael Harvey, David Rosenfeld, David Davies, Bruce M. Hall, Recombinant interferon alpha and hemolytic uremic syndrome: Cause or coincidence? American Journal of Hematology. ,vol. 46, pp. 152- 153 ,(1994) , 10.1002/AJH.2830460220